Question 1

How many shares of EXAS does PRICE T ROWE ASSOCIATES INC /MD/ own?

Accepted Answer

PRICE T ROWE ASSOCIATES INC /MD/ previously held 0 shares of EXAS (EXACT SCIENCES CORP) before exiting the position in 2026-Q1.

Question 2

What is PRICE T ROWE ASSOCIATES INC /MD/'s EXAS position worth?

Accepted Answer

PRICE T ROWE ASSOCIATES INC /MD/'s EXAS position was last reported at $0 in 2026-Q1 before the exit.

Question 3

Is PRICE T ROWE ASSOCIATES INC /MD/ buying or selling EXAS?

Accepted Answer

In 2026-Q1, PRICE T ROWE ASSOCIATES INC /MD/ exited their EXAS position entirely (-100.0% change in shares).

Question 4

When did PRICE T ROWE ASSOCIATES INC /MD/ first buy EXAS?

Accepted Answer

Based on available 13F filings, PRICE T ROWE ASSOCIATES INC /MD/ first reported a position in EXAS in 2019-Q3. They have held the position across 27 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$103.37	0
2025-Q4	Decreased	168,554	-90.2%	$17.1M	0.0%	$101.90	0
2025-Q3	Decreased	1.7M	-53.5%	$94.2M	0.0%	$53.38	0
2025-Q2	Decreased	3.7M	-42.2%	$196.8M	0.0%	$53.65	0
2025-Q1	Increased	6.4M	+11.2%	$277.2M	0.0%	$43.66	34
2024-Q4	Increased	5.8M	+74.7%	$323.7M	0.0%	$56.20	47
2024-Q3	Increased	3.3M	+178.3%	$224.7M	0.0%	$65.96	49
2024-Q2	Decreased	1.2M	-11.9%	$50.1M	0.0%	$42.25	0
2024-Q1	Decreased	1.3M	-6.9%	$92.9M	0.0%	$69.06	0
2023-Q4	Decreased	1.4M	-14.2%	$106.9M	0.0%	$73.98	0
2023-Q3	Decreased	1.7M	-22.9%	$114.8M	0.0%	$68.22	0
2023-Q2	Increased	2.2M	+22.6%	$204.9M	0.0%	$94.28	37
2023-Q1	Decreased	1.8M	-64.3%	$120.7M	0.0%	$66.26	0
2022-Q4	Decreased	5M	-14.1%	$247.2M	0.0%	$49.51	0
2022-Q3	Decreased	5.8M	-62.3%	$188.9M	0.0%	$33.17	0
2022-Q2	Decreased	15.4M	-19.6%	$607.5M	0.1%	$40.58	0
2022-Q1	Increased	19.2M	+39.1%	$1.3B	0.1%	$71.32	50
2021-Q4	Decreased	13.8M	-25.5%	$1.1B	0.1%	$77.89	0
2021-Q3	Decreased	18.5M	-6.5%	$1.8B	0.2%	$91.65	0
2021-Q2	Increased	19.8M	+8.2%	$2.5B	0.2%	$128.14	41
2021-Q1	Increased	18.3M	+10.6%	$2.4B	0.2%	$123.65	42
2020-Q4	Decreased	16.5M	-17.5%	$2.2B	0.2%	$135.40	0
2020-Q3	Decreased	20M	-6.5%	$2B	0.2%	$102.01	0
2020-Q2	Decreased	21.4M	-1.5%	$1.9B	0.2%	$86.02	0
2020-Q1	Increased	21.8M	+16.5%	$1.3B	0.2%	$58.43	44
2019-Q4	Increased	18.7M	+60.9%	$1.7B	0.2%	$91.87	55
2019-Q3	First report	11.6M	-	$1.1B	0.1%	$92.00	0

EXAS27 quarters

EXAS
27 quarters